Contribution of basal and postprandial hyperglycaemia in type 2 diabetes patients treated by an intensified insulin regimen: Impact of pump therapy in the OPT2mise trial.
Yves ReznikAklilu HabteabJavier CastanedaJohn ShinMichael JoubertPublished in: Diabetes, obesity & metabolism (2018)
Basal hyperglycaemia is the major determinant of overall exposure to hyperglycaemia in type 2 diabetes with MDI failure.